Venous Thromboembolism Prevention in Outpatients With Glioma

Abroad (travel likely)RecruitingPHASE2

Conditions

Glioblastoma · Astrocytoma · Venous Thromboembolism

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

University of Vermont Medical Center, Burlington, Vermont, United States

Study leads

Alissa A Thomas, MD
Principal Investigator
University of Vermont Medical Center

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas

Anaplastic Astrocytoma, IDH-Wildtype · Anaplastic Oligoastrocytoma · Anaplastic Oligodendroglioma

Abroad (travel likely)RecruitingPHASE2

Houston, United States

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

High Grade Glioma · Diffuse Intrinsic Pontine Glioma · Anaplastic Astrocytoma

Abroad (travel likely)RecruitingPHASE2

Aurora, United States · Washington D.C., United States

Testing the Addition of an Anti-Cancer Drug, AZD1390, During Radiation Therapy for Newly Diagnosed High Grade Glioma, Diffuse Midline Glioma, or Diffuse Intrinsic Pontine Glioma

Childhood Astrocytoma · Childhood Diffuse Intrinsic Pontine Glioma · Childhood Diffuse Midline Glioma

Abroad (travel likely)RecruitingPHASE1

Birmingham, United States · Los Angeles, United States

ERAS-801 for the Treatment of Resectable and Progressive or Recurrent IDH Wildtype Grade IV Glioblastoma or Astrocytoma With an EGFR Amplification or Mutation, ERAS801-SARG Trial

IDH Wildtype Glioblastoma · Recurrent Astrocytoma · IDH Wildtype Recurrent Glioblastoma

Abroad (travel likely)RecruitingPHASE1

Los Angeles, United States